Results 11 to 20 of about 18,439 (199)

Predictive value of globus pharyngeus in patients with functional dysphonia versus organic dysphonia [PDF]

open access: yes, 2019
Objectives/Hypothesis: This is a retrospective study investigating the prevalence of globus pharyngeus in patients with dysphonia. Study Design: Retrospective chart review.
Elie Khalifee   +9 more
core   +1 more source

Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection

open access: yes, 2008
Michael P Cannito, Joel C Kahane, Lesya ChornaSchool of Audiology and Speech-Language Pathology, The University of Memphis, Memphis, TN, USAAbstract: Aging of the larynx is characterized by involutional changes which alter its biomechanical and neural ...
Lesya Chorna   +5 more
core   +1 more source

Pediatric Dysphonia - A Review

open access: yes, 1970
Dysphonia or hoarseness of voice is defined as a disorder characterized by altered voice quality, loudness, pitch, or vocal effort which impairs the communication or hamper voice-related quality of life. Dysphonia or hoarseness of the voice is a commonly
Sahu, Mahesh Chandra   +4 more
core   +1 more source

Plain Language Summary: Hoarseness (Dysphonia)

open access: yes, 2018
This plain language summary for patients serves as an overview in explaining hoarseness (dysphonia). The summary applies to patients in all age groups and is based on the 2018 “Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).” The evidence ...
Krouse, Helene J.   +9 more
core   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar   +6 more
wiley   +1 more source

A guide to neuromodulation in drug‐resistant epilepsy

open access: yesEpileptic Disorders, EarlyView.
Abstract Neuromodulation is approved for the treatment of drug‐resistant epilepsy. It has been increasingly utilized over the past two decades with the approval of deep brain stimulation (DBS) and responsive neurostimulation (RNS) in addition to vagus nerve stimulation (VNS)—particularly in patients who are not deemed to be good resective surgical ...
Prachi Parikh   +10 more
wiley   +1 more source

Effectiveness and safety of implantable vagus nerve stimulation in people with primary generalized tonic–clonic seizures

open access: yesEpilepsia Open, EarlyView.
The impact of prompt diagnosis and treatment, and early predictors of outcome severity in this cohort. Abstract Objective Most therapies for drug‐resistant epilepsy (DRE) focus on focal‐onset seizures, the most common seizure types. Studying primary generalized tonic–clonic seizures (PGTCS) is more challenging due to diagnostic and recruitment ...
Katherine Eggleston   +6 more
wiley   +1 more source

Vocal therapy of hyperkinetic dysphonia

open access: yes, 2014
Introduction. Hyperkinetic (hyperfunctional) dysphonia is a common pathology. The disorder is often found in vocal professionals faced with high vocal requirements. Objective.
Veselinović Mila   +3 more
core   +1 more source

Brain–Computer Interfaces: The Dawn of a New Era in Disease Treatment

open access: yesExploration, EarlyView.
This study investigates the potential of brain–computer interface (BCI) technology in treating neuropsychiatric disorders, such as movement and communication barriers. Our review examines the history, signal paradigms, and diverse applications of BCI while also discussing ongoing research into novel materials and emerging technologies that offer ...
Yuqi Feng   +11 more
wiley   +1 more source

Research priorities in spasmodic dysphonia

open access: yes, 2008
Objective To identify research priorities to increase understanding of the pathogenesis, diagnosis, and improved treatment of spasmodic dysphonia.
Blitzer, Andrew   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy